Cargando…
Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management
Organophosphorus compounds are absorbed by any route including intramuscular injection. Pyrethroid compounds are less toxic for human but in combination with organophosphates, its toxic effect potentiates due to inhibition of its metabolism. In this case report, a 40-year-old female patient presente...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380745/ https://www.ncbi.nlm.nih.gov/pubmed/32754535 http://dx.doi.org/10.4103/jfmpc.jfmpc_16_20 |
_version_ | 1783562900993998848 |
---|---|
author | Nizami, Mohammad Firoz Sharma, Chandra B. Singh, Bhoopendra Guria, Rishi T. |
author_facet | Nizami, Mohammad Firoz Sharma, Chandra B. Singh, Bhoopendra Guria, Rishi T. |
author_sort | Nizami, Mohammad Firoz |
collection | PubMed |
description | Organophosphorus compounds are absorbed by any route including intramuscular injection. Pyrethroid compounds are less toxic for human but in combination with organophosphates, its toxic effect potentiates due to inhibition of its metabolism. In this case report, a 40-year-old female patient presented with acute onset of pain abdomen, recurrent vomiting, and excessive salivation followed by altered mental status, on evaluation her clinical findings were suggestive of organophosphorus poisoning. Her treatment was started with injection atropine, anti-emetics, and adequate parenteral rehydration. After regaining consciousness, the patient confessed that she had taken herself intramuscular injection of pesticide which contained 3% cypermethrine plus 20% quinolphos. It was further confirmed by a very low level of plasma cholinesterase level. Intramuscular injection acted as a depot that leads to prolong intoxication and in the due course of illness, she also developed delayed onset intermediate syndrome that was managed appropriately. |
format | Online Article Text |
id | pubmed-7380745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-73807452020-08-03 Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management Nizami, Mohammad Firoz Sharma, Chandra B. Singh, Bhoopendra Guria, Rishi T. J Family Med Prim Care Case Report Organophosphorus compounds are absorbed by any route including intramuscular injection. Pyrethroid compounds are less toxic for human but in combination with organophosphates, its toxic effect potentiates due to inhibition of its metabolism. In this case report, a 40-year-old female patient presented with acute onset of pain abdomen, recurrent vomiting, and excessive salivation followed by altered mental status, on evaluation her clinical findings were suggestive of organophosphorus poisoning. Her treatment was started with injection atropine, anti-emetics, and adequate parenteral rehydration. After regaining consciousness, the patient confessed that she had taken herself intramuscular injection of pesticide which contained 3% cypermethrine plus 20% quinolphos. It was further confirmed by a very low level of plasma cholinesterase level. Intramuscular injection acted as a depot that leads to prolong intoxication and in the due course of illness, she also developed delayed onset intermediate syndrome that was managed appropriately. Wolters Kluwer - Medknow 2020-05-31 /pmc/articles/PMC7380745/ /pubmed/32754535 http://dx.doi.org/10.4103/jfmpc.jfmpc_16_20 Text en Copyright: © 2020 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Nizami, Mohammad Firoz Sharma, Chandra B. Singh, Bhoopendra Guria, Rishi T. Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management |
title | Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management |
title_full | Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management |
title_fullStr | Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management |
title_full_unstemmed | Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management |
title_short | Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management |
title_sort | intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380745/ https://www.ncbi.nlm.nih.gov/pubmed/32754535 http://dx.doi.org/10.4103/jfmpc.jfmpc_16_20 |
work_keys_str_mv | AT nizamimohammadfiroz intramuscularpyrethroidwithorganophosphoruscypermethrine3quinolphos20mixedpoisoningitsclinicalpresentationandmanagement AT sharmachandrab intramuscularpyrethroidwithorganophosphoruscypermethrine3quinolphos20mixedpoisoningitsclinicalpresentationandmanagement AT singhbhoopendra intramuscularpyrethroidwithorganophosphoruscypermethrine3quinolphos20mixedpoisoningitsclinicalpresentationandmanagement AT guriarishit intramuscularpyrethroidwithorganophosphoruscypermethrine3quinolphos20mixedpoisoningitsclinicalpresentationandmanagement |